PATENT CLAIM ANALYSIS

Application Number: 15963535
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210200"]

Abstract:
The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.

Claim (Index 11):
A method of treating respiratory diseases, allergies, rheumatoid arthritis, osteoarthritis, rheumatic disorders, psoriasis, ulcerative colitis, Crohn's disease, septic shock, proliferative disorders such as cancer, atherosclerosis, allograft rejection following transplantation, diabetes, stroke, obesity and restenosis, comprising administering to a subject in need thereof a therapeutically effective amount of a compound or salt according to  claim 1 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15303879', '15303868', '15303890', '12765904', '15736450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8149576061106208
- 35 USC 102 Novelty (BERT): 0.5754680696767712
- Combined Prediction Score: 0.7910086524672358
- Mean Citation Score: 436.623092
- Max Citation Score: 539.0702
- Similarity Product: 370.2554569313288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test